PRICE T ROWE ASSOCIATES INC /MD/ - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 75 filers reported holding DESIGN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$4,684,000
-5.3%
280,120
-20.7%
0.00%0.0%
Q2 2022$4,944,000
-46.7%
353,109
-38.5%
0.00%0.0%
Q1 2022$9,270,000
-45.0%
574,012
-27.1%
0.00%
-50.0%
Q4 2021$16,864,000
-20.8%
787,665
-45.6%
0.00%0.0%
Q3 2021$21,285,000
-24.4%
1,448,9680.0%0.00%
-33.3%
Q2 2021$28,168,000
-32.8%
1,448,968
+1.0%
0.00%
-25.0%
Q1 2021$41,934,0001,435,2540.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders